Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) vs Hypoport SE (HYPOF)
A side-by-side comparison of Drugs Made In America Acquisition II Corp. Ordinary Shares and Hypoport SE across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — DMII vs HYPOF
growth of $100 · dividends reinvested · last 1yDMII vs HYPOF: by the numbers
- •DMII is the larger company ($649M vs $631M market cap).
- •HYPOF trades at the lower trailing earnings multiple (18.99 vs 34.76 P/E), one valuation lens rather than an overall verdict.
- •HYPOF is profitable (4.63% net margin) while DMII runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | DMII | HYPOF |
|---|---|---|
| P/E ratio | 34.76 | 18.99 |
| P/S ratio | N/A | 0.88 |
| P/B ratio | 1.31 | 1.44 |
Profitability
| Metric | DMII | HYPOF |
|---|---|---|
| Gross margin | 0.00% | N/A |
| Operating margin | 0.00% | 4.49% |
| Net margin | 0.00% | 4.63% |
| ROE | 2.62% | 7.58% |
| ROIC | -0.28% | N/A |
Hypoport SE: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.
Growth (annualized)
| Metric | DMII | HYPOF |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.95% |
| EPS CAGR (5Y) | N/A | -2.99% |
| Total return CAGR (5Y) | N/A | -31.74% |
Frequently asked
- Which has the lower trailing P/E, DMII or HYPOF?
- HYPOF has the lower trailing P/E: DMII trades at 34.76 and HYPOF at 18.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is DMII or HYPOF more profitable?
- HYPOF runs the higher net margin — DMII at 0.00% versus HYPOF at 4.63%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.